CHOLINERGICS, ANTICHOLINERGICS & ANTICHOLINESTERASES

Slides:



Advertisements
Similar presentations
SYNAPSES AND DRUGS.
Advertisements

Efferent Division: Autonomic and Somatic Motor Control
INDIRECT CHOLINOMIMETICS Pharmacology Department
DIRECT CHOLINERGIC DRUGS Pharmacology Department
Direct cholinomimetic (Parasympathomimetics) Drugs
Signal transmission at synapses Alice Skoumalová.
Overview of Nervous System Parasympathetic Responses.
Neuromuscular Transmission synaptic transmission between a somatic motor neuron and a skeletal muscle fiber Somatic Fig
Pharmacology-1 PHL 313 Parasympathetic Nervous System Second Lecture By Abdelkader Ashour, Ph.D. Phone:
1 © Patrick An Introduction to Medicinal Chemistry 3/e Chapter 6 PROTEINS AS DRUG TARGETS: RECEPTOR STRUCTURE & SIGNAL TRANSDUCTION Part 1: Sections 6.1.
Cholinergic agonists & Cholinergic antagonists
Cholinergics, anticholinergics and antcholinesterases Nervous System Peripheral NS Sensory nerves Motor nerves Central NS (Brain and Spinal cord) Sensory.
© 2013 Pearson Education, Inc. Chapter 18, Section 6 4/13/2013 Chemical Messengers Neurotransmitters Hormones Supplemental.
Receptors and Drug Action Receptors: Specific areas of cell membranes (proteins, glycoproteins)* When bound to ligand, positive or negative biological.
UNIT 2 CHOLINOMIMETICS.
The Autonomic Nervous System
The Peripheral Nervous System: Efferent Division
DIRECT CHOLINERGIC DRUGS Prof. Hanan Hagar Pharmacology Department.
1 Alzheimer’s Disease & Acetylcholine Presentation by: Huy Nguyen Chemistry 12B Instructor: Dr. Adamczeski Fall-2006.
Cholinergic transmission Lecture 8. Learning outcome: Muscarinic and nicotinic actions of acetylcholine Acetylcholine receptors Physiology of cholinergic.
CHOLINOCEPTOR ACTIVATING DRUGS
Clinical Pharmacology Autonomic pharmacology Jane M Johnston Ph.D.
1 © Patrick An Introduction to Medicinal Chemistry 3/e Chapter 19 CHOLINERGICS, ANTICHOLINERGICS & ANTICHOLINESTERASES Part 1: Cholinergics & anticholinesterases.
1 © Patrick An Introduction to Medicinal Chemistry 3/e Chapter 10 DRUG DESIGN: OPTIMIZING TARGET INTERACTIONS Part 1: Section 10.1 (SAR)
The Nervous System Neuron –Cell body; Dendrites; Axon Three general groups of neurons –Sensory neurons (afferent or receptor) Receive the initial stimulus.
DIRECT CHOLINERGIC DRUGS Profs. Abdalqader Alhaider & Hanan Hagar
Neurons: Cellular and Network Properties
1 © Patrick An Introduction to Medicinal Chemistry 3/e Chapter 19 CHOLINERGICS, ANTICHOLINERGICS & ANTICHOLINESTERASES Part 3: Cholinergics & anticholinesterases.
INDIRECT CHOLINOMIMETICS Prof. Alhaider Pharmacology Department Prof. Hanan Hagar Pharmacology Department.
Dr. Mohd Nazam Ansari Nervous System which consists of is divided into that make up which is divided into The Nervous System Sensory nerves (Afferent.
INDIRECT CHOLINOMIMETICS Prof. Hanan Hagar Pharmacology Department.
The Synapse A synapse is the functional connection between a neuron and a second cell. The second cell is also a neuron in CNS. In the PNS, the second.
Autonomic Nervous System (ANS) Cholinergic Drugs 1 أ 0 م 0 د. وحدة بشير اليوزبكي.
ANS Review.
DRUG DESIGN: OPTIMIZING TARGET INTERACTIONS
Modeling the Neuromuscular Junction
Chapter 6: Introduction to Autonomic Pharmacology
INDIRECT CHOLINOMIMETICS Pharmacology Department
INDIRECT CHOLINOMIMETICS
Autonomic Nervous System-II
CHOLINERGIC TRANSMISSION
Receptors and Drug Action
Chapter 10 Nervous System.
Central Nervous System (CNS)
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
Autonomic nervous system
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
Cholinergic Drug Lecture 4-7
Anticholinesterase Drugs and Cholinergic Agonists
Cholinergic Drug Lecture 4, 5 &6
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
School of Pharmacy, University of Nizwa
INTRODUCTION TO NEUROBIOLOGY
INTRODUCTION TO NEUROBIOLOGY
Pharmacology of Autonomic Nervous System
SYNAPSES AND DRUGS.
Cholinergic Antagonist
Cholinergic Antagonist
School of Pharmacy, University of Nizwa
Cholinergic Acting Drugs Pharmaceutical Medicinal Chemistry-I
SYNAPSES AND DRUGS.
Receptors & Drug action at Receptors
Patrick: An Introduction to Medicinal Chemistry 6e
INDIRECT CHOLINOMIMETICS
SYNAPSES AND DRUGS.
Module 1 Communication and homeostasis
SYMPATHETIC Increase BP & HR, glucose Perfusion to skeletal muscles Mydriasis, bronchodilatation PARASYMPATHETIC Miosis, decreased HR, BP, bronchia secretion,
Patrick: An Introduction to Medicinal Chemistry 5e ANTICANCER AGENTS
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
Presentation transcript:

CHOLINERGICS, ANTICHOLINERGICS & ANTICHOLINESTERASES Patrick An Introduction to Medicinal Chemistry 3/e Chapter 19 CHOLINERGICS, ANTICHOLINERGICS & ANTICHOLINESTERASES Part 1: Cholinergics & anticholinesterases

Contents Part 1: Cholinergics & anticholinesterases 1. Nerve Transmission (3 slides) 2. Neurotransmitter 3. Transmission process (10 slides) 4. Cholinergic receptors (2 slides) 4.1. Nicotinic receptor (2 slides) 4.2. Muscarinic receptor - G Protein coupled receptor (2 slides) 5. Cholinergic agonists 5.1. Acetylcholine as an agonist 5.2. Nicotine and muscarine as cholinergic agonists 5.3. Requirements for cholinergic agonists 6. SAR for acetlcholine (6 slides) 7. Binding site (muscarinic) (3 slides) 8. Active conformation of acetylcholine (2 slides) 9. Instability of acetylcholine 10. Design of cholinergic agonists (7 slides) 11. Uses of cholinergic agonists (2 slides) [46 slides]

CHOLINERGIC NERVOUS SYSTEM

1. Nerve Transmission Peripheral nervous system CNS Brain Peripheral nerves Muscle Heart Gastro- intestinal tract (GIT) Spinal cord

http://trc. ucdavis. edu/biosci10v/bis10v/media/ch25/nervous_divisions http://trc.ucdavis.edu/biosci10v/bis10v/media/ch25/nervous_divisions.swf http://trc.ucdavis.edu/biosci10v/bis10v/media/ch25/nervous_divisions.swf

1. Nerve Transmission Peripheral nervous system Skeletal muscle CNS (Somatic) (Autonomic) Ach (N) Synapse AUTONOMIC Smooth muscle Cardiac muscle Ach (N) NA Adrenal medulla Sympathetic Parasympathetic Adrenaline Ach (N) Synapse Ach (M) Ach (N)

http://entochem.tamu.edu/neurobiology/index.html

1. Nerve Transmission Synapses 100-500A Receptors New signal Nerve impulse Nerve Vesicles containing neurotransmitters Release of neurotransmitters Receptor binding and new signal

2. Neurotransmitter Acetylcholine (Ach) H 3 C O N M e + Choline Acetyl

. . 3. Transmission process Signal in nerve 1 Nerve 2 Nerve 1 Signal Acetylcholine Acetylcholinesterase enzyme Cholinergic receptor Vesicle

3. Transmission process Vesicles fuse with membrane and release Ach Nerve 1 Nerve 2 Signal

3. Transmission process Nerve 2

3. Transmission process Receptor binds Ach Nerve 2 Receptor binds Ach Induced fit triggers 2o message Triggers firing of nerve 2 Ach undergoes no reaction 2o Message

3. Transmission process Ach departs receptor Nerve 2 Ach departs receptor Receptor reverts to resting state Ach binds to acetylcholinesterase

3. Transmission process Nerve 2 Ach hydrolysed by acetylcholinesterase

3. Transmission process Choline binds to carrier protein Choline Nerve 1 Nerve 2 Choline Carrier protein for choline

3. Transmission process Choline transported into nerve Nerve 1 Nerve 2

3. Transmission process Ach resynthesised Nerve 2 Nerve 1 E 1 = Choline acetyltransferase

3. Transmission process Ach repackaged in vesicles Nerve 1 Nerve 2

4. Cholinergic receptors Receptor types Not all cholinergic receptors are identical Two types of cholinergic receptor - nicotinic and muscarinic Named after natural products showing receptor selectivity Nicotine L-(+)-Muscarine Activates cholinergic receptors at nerve synapses and on skeletal muscle Activates cholinergic receptors on smooth muscle and cardiac muscle Acetylcholine is natural messenger for both receptor types

Peripheral nervous system Skeletal Muscle SOMATIC CNS (Somatic) (Autonomic) Ach (N) Synapse AUTONOMIC Smooth Muscle Cardiac Muscle Ach (N) NA Adrenal medulla Sympathetic Parasympathetic Adrenaline Ach (N) Synapse Ach (M) Ach (N)

4.1 Nicotinic receptor Control of Cationic Ion Channel: Binding site Messenger Cell membrane Five glycoprotein subunits traversing cell membrane Cell membrane Induced fit ‘Gating’ (ion channel opens)

4.1 Nicotinic receptor The binding sites Binding sites Ion channel Two ligand binding sites mainly on a-subunits Ion channel Cell membrane a d b g 2xa, b, g, d subunits

4.2 Muscarinic receptor - G Protein coupled receptor Activation of a signal protein Receptor binds messenger leading to an induced fit Opens a binding site for a signal protein (G-protein) messenger induced fit G-protein bound open closed G-protein split

4.2 Muscarinic receptor - G Protein coupled receptor Activation of membrane bound enzyme G-Protein is split and subunit activates a membrane bound enzyme Subunit binds to an allosteric binding site on enzyme Induced fit results in opening of an active site Intracellular reaction is catalysed Enzyme Enzyme subunit active site (open) active site (closed) Intracellular reaction

5. Cholinergic agonists 5.1 Acetylcholine as an agonist Advantages Natural messenger Easily synthesised Disadvantages Easily hydrolysed in stomach (acid catalysed hydrolysis) Easily hydrolysed in blood (esterases) No selectivity between receptor types No selectivity between different target organs

5. Cholinergic agonists 5.2 Nicotine and muscarine as cholinergic agonists Advantages More stable than Ach Selective for main cholinergic receptor types Selective for different organs Disadvantages Activate receptors for other chemical messengers Side effects

5. Cholinergic agonists 5.3 Requirements for cholinergic agonists Stability to stomach acids and esterases Selectivity for cholinergic receptors Selectivity between muscarinic and nicotinic receptors Knowledge of binding site SAR for acetylcholine

6. SAR for acetlcholine Quaternary nitrogen is essential Acetoxy Ethylene bridge Nitrogen Acetoxy Ethylene bridge 4 o Nitrogen Quaternary nitrogen is essential Bad for activity

6. SAR for acetylcholine Acetoxy Ethylene bridge Nitrogen Acetoxy Ethylene bridge 4 o Nitrogen Distance from quaternary nitrogen to ester is important Ethylene bridge must be retained Bad for activity

6. SAR for acetylcholine Ester is important Bad for activity Acetoxy Ethylene bridge Nitrogen Acetoxy Ethylene bridge 4 o Nitrogen Ester is important Bad for activity

6. SAR for acetylcholine Acetoxy Ethylene bridge 4 o Nitrogen Acetoxy Ethylene bridge 4 o Nitrogen Minimum of two methyl groups on quaternary nitrogen Bad for activity Active

6. SAR for acetylcholine Acetoxy Ethylene bridge Nitrogen Acetoxy Ethylene bridge 4 o Nitrogen Methyl group of acetoxy group cannot be extended Bad for activity

6. SAR for acetylcholine Conclusions: Acetoxy Ethylene bridge 4 o Nitrogen Conclusions: Tight fit between Ach and binding site Methyl groups fit into small hydrophobic pockets Ester interacting by H-bonding Quaternary nitrogen interacting by ionic bonding

7. Binding site (muscarinic) Trp-307 Asp311 Trp-613 Trp-616 Asn-617 hydrophobic pocket pockets

7. Binding site (muscarinic) Trp-307 Asp311 Trp-613 Trp-616 Asn-617 vdw Ionic bond H-bonds

7. Binding site (muscarinic) Possible induced dipole dipole interaction between quaternary nitrogen and hydrophobic aromatic rings in binding site N+ induces dipole in aromatic rings d + d -

8. Active conformation of acetylcholine Several freely rotatable single bonds Large number of possible conformations Active conformation does not necessarily equal the most stable conformation

8. Active conformation of acetylcholine Rigid Analogues of acetylcholine Rotatable bonds ‘locked’ within ring Restricts number of possible conformations Defines separation of ester and N Muscarinic receptor Nicotinic receptor

9. Instability of acetylcholine Neighbouring group participation Increases electrophilicity of carbonyl group Increases sensitivity to nucleophiles

10. Design of cholinergic agonists Requirements Correct size Correct pharmacophore - ester and quaternary nitrogen Increased stability to acid and esterases Increased selectivity

10. Design of cholinergic agonists Use of steric shields Rationale Shields protect ester from nucleophiles and enzymes Shield size is important Must be large enough to hinder hydrolysis Must be small enough to fit binding site

10. Design of cholinergic agonists hinders binding to esterases and provides a shield to nucleophilic attack Methacholine asymmetric centre Properties Three times more stable than acetylcholine Increasing the shield size increases stability but decreases activity Selective for muscarinic receptors over nicotinic receptors S-enantiomer is more active than the R-enantiomer Stereochemistry matches muscarine Not used clinically

= 10. Design of cholinergic agonists Use of electronic factors Replace ester with urethane Stabilises the carbonyl group =

10. Design of cholinergic agonists Carbachol Properties Resistant to hydrolysis Long lasting NH2 and CH3 are equal sizes. Both fit the hydrophobic pocket NH2 = bio-isostere Muscarinic activity = nicotinic activity Used topically for glaucoma

10. Design of cholinergic agonists Steric + Electronic factors Bethanechol Properties Very stable Orally active Selective for the muscarinic receptor Used to stimulate GI tract and urinary bladder after surgery

10. Design of cholinergic agonists Nicotinic selective agonist

11. Uses of cholinergic agonists Nicotinic selective agonists Treatment of myasthenia gravis - lack of acetylcholine at skeletal muscle causing weakness Muscarinic selective agonists Treatment of glaucoma Switching on GIT and urinary tract after surgery Treatment of certain heart defects. Decreases heart muscle activity and decreases heart rate

Peripheral nervous system Skeletal Muscle SOMATIC CNS (Somatic) (Autonomic) Ach (N) Synapse AUTONOMIC Smooth Muscle Cardiac Muscle Ach (N) NA Adrenal medulla Sympathetic Parasympathetic Adrenaline Ach (N) Synapse Ach (M) Ach (N)